Clinical trial
Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent…
NCT00461084 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00461084 |
|---|---|
| Title | Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma |
| Official title | Biaxin(Clarithromycin)Based Antibiotic Therapy In Previously Untreated, Advanced Stage Indolent Lymphoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | BIAXIN (CLARITHROMYCIN), Biaxin (clarithromycin) |
| Enrollment | 36 |
| Start date | Apr 1, 2007 |
| Primary completion | Sep 1, 2014 |
| Completion | Sep 1, 2014 |
| First posted | Apr 17, 2007 |
| Last update posted | Sep 18, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: